MARG PHARMACY INC has sponsored the creation of one or more 401k plans.
| Measure | Date | Value |
|---|
| 2023 : MEDLY PHARMACY 401K 2023 401k financial data |
|---|
| Total unrealized appreciation/depreciation of assets | 2023-05-10 | $0 |
| Total liabilities at end of year (benefit claims payable, operating payabales, acquisition indebtedness and other liabilities) | 2023-05-10 | $0 |
| Total liabilities at beginning of year (benefit claims payable, operating payabales, acquisition indebtedness and other liabilities) | 2023-05-10 | $0 |
| Total income from all sources (including contributions) | 2023-05-10 | $852,866 |
| Total loss/gain on sale of assets | 2023-05-10 | $0 |
| Total of all expenses incurred | 2023-05-10 | $9,076,150 |
| Benefit payments and payments to participlants,beneficiaries,insurance carriers and others | 2023-05-10 | $9,011,206 |
| Total contributions o plan (from employers,participants, others, non cash contrinutions) | 2023-05-10 | $399,478 |
| Value of total assets at end of year | 2023-05-10 | $0 |
| Value of total assets at beginning of year | 2023-05-10 | $8,223,284 |
| Total of administrative expenses incurred including professional, contract, advisory and management fees | 2023-05-10 | $64,944 |
| Total interest from all sources | 2023-05-10 | $8 |
| Total dividends received (eg from common stock, registered investment company shares) | 2023-05-10 | $7,150 |
| Has a resolution to terminate the plan been adopted during the plan year or any prior plan year | 2023-05-10 | Yes |
| Value of any plan assets that reverted to the employer resulting from resoluton to terminate the plan | 2023-05-10 | $0 |
| Total dividends received from registered investment company shares (eg mutual funds) | 2023-05-10 | $7,150 |
| Was this plan covered by a fidelity bond | 2023-05-10 | Yes |
| Value of fidelity bond cover | 2023-05-10 | $500,000 |
| If this is an individual account plan, was there a blackout period | 2023-05-10 | No |
| Were there any nonexempt tranactions with any party-in-interest | 2023-05-10 | No |
| Contributions received from participants | 2023-05-10 | $220,421 |
| Participant contributions at beginning of year | 2023-05-10 | $1,901 |
| Participant contributions at beginning of year | 2023-05-10 | $19,147 |
| Income. Received or receivable in cash from other sources (including rollovers) | 2023-05-10 | $179,057 |
| Expenses. Other payments made (not to insurance carriers or or participants/beneficiaries) | 2023-05-10 | $4 |
| Did the receive any noncash contributions whose value was neither redily determinable on an established market nor set by an independent third party appraiser | 2023-05-10 | No |
| Value of net income/loss | 2023-05-10 | $-8,223,284 |
| Value of net assets at end of year (total assets less liabilities) | 2023-05-10 | $0 |
| Value of net assets at beginning of year (total assets less liabilities) | 2023-05-10 | $8,223,284 |
| Did the plan have a loss casued by fraud or dishonesty (regardless whether reimbursed by fidelity bond) | 2023-05-10 | No |
| Were any loans by the plan or fixed income obligations due to the plan in default | 2023-05-10 | No |
| Were any leases to which the plan was party in default or uncollectible | 2023-05-10 | No |
| Value of interest in registered invesment companies (eg mutual funds) at beginning of year | 2023-05-10 | $7,949,113 |
| Value of interest in pooled separate accounts at beginning of year | 2023-05-10 | $147,957 |
| Interest on participant loans | 2023-05-10 | $8 |
| Value of interest in common/collective trusts at beginning of year | 2023-05-10 | $105,166 |
| Net investment gain/loss from registered investment companies (e.g. mutual funds) | 2023-05-10 | $434,907 |
| Net investment gain/loss from pooled separate accounts | 2023-05-10 | $10,559 |
| Net investment gain or loss from common/collective trusts | 2023-05-10 | $764 |
| Were any plan transactions or series of transactions in excess of 5% of the current value of the plan assets | 2023-05-10 | No |
| Was there a failure to transmit to the plan any participant contributions | 2023-05-10 | Yes |
| Has the plan failed to provide any benefit when due under the plan | 2023-05-10 | No |
| Benefit payments and payments to provide benefits directly to participlants or beneficiaries including direct rollovers | 2023-05-10 | $9,011,202 |
| Contract administrator fees | 2023-05-10 | $37,946 |
| Did the plan have assets held for investment | 2023-05-10 | No |
| Did the plan hold any assets whose current value was neither redily determinable on an established market nor set by an independent third party appraiser | 2023-05-10 | No |
| Were all the plan assets eitehr distributed to particpants/beneficiaries, transferred to another plan or brought under the control of the PBGC | 2023-05-10 | Yes |
| Opinion of an independent qualified public accountant for this plan | 2023-05-10 | Unqualified |
| Accountancy firm name | 2023-05-10 | SEE ATTACHED REASONABLE CAUSE |
| Accountancy firm EIN | 2023-05-10 | 223315838 |
| 2022 : MEDLY PHARMACY 401K 2022 401k financial data |
|---|
| Total unrealized appreciation/depreciation of assets | 2022-12-31 | $0 |
| Total liabilities at end of year (benefit claims payable, operating payabales, acquisition indebtedness and other liabilities) | 2022-12-31 | $0 |
| Total liabilities at beginning of year (benefit claims payable, operating payabales, acquisition indebtedness and other liabilities) | 2022-12-31 | $0 |
| Total income from all sources (including contributions) | 2022-12-31 | $4,544,677 |
| Total loss/gain on sale of assets | 2022-12-31 | $0 |
| Total of all expenses incurred | 2022-12-31 | $2,788,627 |
| Benefit payments and payments to participlants,beneficiaries,insurance carriers and others | 2022-12-31 | $2,695,948 |
| Total contributions o plan (from employers,participants, others, non cash contrinutions) | 2022-12-31 | $6,117,314 |
| Value of total assets at end of year | 2022-12-31 | $8,223,284 |
| Value of total assets at beginning of year | 2022-12-31 | $6,467,234 |
| Total of administrative expenses incurred including professional, contract, advisory and management fees | 2022-12-31 | $92,679 |
| Total interest from all sources | 2022-12-31 | $1,930 |
| Total dividends received (eg from common stock, registered investment company shares) | 2022-12-31 | $161,265 |
| Has a resolution to terminate the plan been adopted during the plan year or any prior plan year | 2022-12-31 | No |
| Total dividends received from registered investment company shares (eg mutual funds) | 2022-12-31 | $161,265 |
| Administrative expenses professional fees incurred | 2022-12-31 | $26,103 |
| Was this plan covered by a fidelity bond | 2022-12-31 | Yes |
| Value of fidelity bond cover | 2022-12-31 | $500,000 |
| If this is an individual account plan, was there a blackout period | 2022-12-31 | No |
| Were there any nonexempt tranactions with any party-in-interest | 2022-12-31 | No |
| Contributions received from participants | 2022-12-31 | $3,212,790 |
| Participant contributions at end of year | 2022-12-31 | $1,901 |
| Participant contributions at beginning of year | 2022-12-31 | $34,534 |
| Participant contributions at end of year | 2022-12-31 | $19,147 |
| Participant contributions at beginning of year | 2022-12-31 | $122,610 |
| Income. Received or receivable in cash from other sources (including rollovers) | 2022-12-31 | $2,861,615 |
| Expenses. Other payments made (not to insurance carriers or or participants/beneficiaries) | 2022-12-31 | $78,142 |
| Other income not declared elsewhere | 2022-12-31 | $622 |
| Did the receive any noncash contributions whose value was neither redily determinable on an established market nor set by an independent third party appraiser | 2022-12-31 | No |
| Value of net income/loss | 2022-12-31 | $1,756,050 |
| Value of net assets at end of year (total assets less liabilities) | 2022-12-31 | $8,223,284 |
| Value of net assets at beginning of year (total assets less liabilities) | 2022-12-31 | $6,467,234 |
| Did the plan have a loss casued by fraud or dishonesty (regardless whether reimbursed by fidelity bond) | 2022-12-31 | No |
| Were any loans by the plan or fixed income obligations due to the plan in default | 2022-12-31 | No |
| Were any leases to which the plan was party in default or uncollectible | 2022-12-31 | No |
| Value of interest in registered invesment companies (eg mutual funds) at end of year | 2022-12-31 | $7,949,113 |
| Value of interest in registered invesment companies (eg mutual funds) at beginning of year | 2022-12-31 | $6,196,339 |
| Value of interest in pooled separate accounts at end of year | 2022-12-31 | $147,957 |
| Value of interest in pooled separate accounts at beginning of year | 2022-12-31 | $93,877 |
| Interest on participant loans | 2022-12-31 | $1,930 |
| Value of interest in common/collective trusts at end of year | 2022-12-31 | $105,166 |
| Value of interest in common/collective trusts at beginning of year | 2022-12-31 | $19,874 |
| Net investment gain/loss from registered investment companies (e.g. mutual funds) | 2022-12-31 | $-1,685,100 |
| Net investment gain/loss from pooled separate accounts | 2022-12-31 | $-53,064 |
| Net investment gain or loss from common/collective trusts | 2022-12-31 | $1,710 |
| Were any plan transactions or series of transactions in excess of 5% of the current value of the plan assets | 2022-12-31 | No |
| Was there a failure to transmit to the plan any participant contributions | 2022-12-31 | Yes |
| Has the plan failed to provide any benefit when due under the plan | 2022-12-31 | No |
| Contributions received in cash from employer | 2022-12-31 | $42,909 |
| Benefit payments and payments to provide benefits directly to participlants or beneficiaries including direct rollovers | 2022-12-31 | $2,617,806 |
| Contract administrator fees | 2022-12-31 | $66,576 |
| Did the plan have assets held for investment | 2022-12-31 | Yes |
| Did the plan hold any assets whose current value was neither redily determinable on an established market nor set by an independent third party appraiser | 2022-12-31 | No |
| Were all the plan assets eitehr distributed to particpants/beneficiaries, transferred to another plan or brought under the control of the PBGC | 2022-12-31 | No |
| Opinion of an independent qualified public accountant for this plan | 2022-12-31 | Unqualified |
| Accountancy firm name | 2022-12-31 | SEE ATTACHED REASONABLE CAUSE |
| Accountancy firm EIN | 2022-12-31 | 223315838 |
| 2021 : MEDLY PHARMACY 401K 2021 401k financial data |
|---|
| Total unrealized appreciation/depreciation of assets | 2021-12-31 | $0 |
| Total liabilities at end of year (benefit claims payable, operating payabales, acquisition indebtedness and other liabilities) | 2021-12-31 | $0 |
| Total liabilities at beginning of year (benefit claims payable, operating payabales, acquisition indebtedness and other liabilities) | 2021-12-31 | $0 |
| Total income from all sources (including contributions) | 2021-12-31 | $6,150,884 |
| Total loss/gain on sale of assets | 2021-12-31 | $0 |
| Total of all expenses incurred | 2021-12-31 | $445,251 |
| Benefit payments and payments to participlants,beneficiaries,insurance carriers and others | 2021-12-31 | $431,997 |
| Value of total corrective distributions | 2021-12-31 | $1,030 |
| Total contributions o plan (from employers,participants, others, non cash contrinutions) | 2021-12-31 | $5,909,842 |
| Value of total assets at end of year | 2021-12-31 | $6,467,234 |
| Value of total assets at beginning of year | 2021-12-31 | $761,601 |
| Total of administrative expenses incurred including professional, contract, advisory and management fees | 2021-12-31 | $12,224 |
| Total interest from all sources | 2021-12-31 | $1,981 |
| Total dividends received (eg from common stock, registered investment company shares) | 2021-12-31 | $95,447 |
| Has a resolution to terminate the plan been adopted during the plan year or any prior plan year | 2021-12-31 | No |
| Total dividends received from registered investment company shares (eg mutual funds) | 2021-12-31 | $95,447 |
| Was this plan covered by a fidelity bond | 2021-12-31 | No |
| If this is an individual account plan, was there a blackout period | 2021-12-31 | No |
| Total value of distributions paid in property other than in cash, annuity contracts, or publicly traded employer securities | 2021-12-31 | $0 |
| Were there any nonexempt tranactions with any party-in-interest | 2021-12-31 | No |
| Contributions received from participants | 2021-12-31 | $1,682,301 |
| Participant contributions at end of year | 2021-12-31 | $34,534 |
| Participant contributions at beginning of year | 2021-12-31 | $43,632 |
| Participant contributions at end of year | 2021-12-31 | $122,610 |
| Participant contributions at beginning of year | 2021-12-31 | $29,373 |
| Income. Received or receivable in cash from other sources (including rollovers) | 2021-12-31 | $4,227,541 |
| Expenses. Other payments made (not to insurance carriers or or participants/beneficiaries) | 2021-12-31 | $19,180 |
| Did the receive any noncash contributions whose value was neither redily determinable on an established market nor set by an independent third party appraiser | 2021-12-31 | No |
| Value of net income/loss | 2021-12-31 | $5,705,633 |
| Value of net assets at end of year (total assets less liabilities) | 2021-12-31 | $6,467,234 |
| Value of net assets at beginning of year (total assets less liabilities) | 2021-12-31 | $761,601 |
| Did the plan have a loss casued by fraud or dishonesty (regardless whether reimbursed by fidelity bond) | 2021-12-31 | No |
| Were any loans by the plan or fixed income obligations due to the plan in default | 2021-12-31 | No |
| Were any leases to which the plan was party in default or uncollectible | 2021-12-31 | No |
| Value of interest in registered invesment companies (eg mutual funds) at end of year | 2021-12-31 | $6,196,339 |
| Value of interest in registered invesment companies (eg mutual funds) at beginning of year | 2021-12-31 | $677,404 |
| Value of interest in pooled separate accounts at end of year | 2021-12-31 | $93,877 |
| Value of interest in pooled separate accounts at beginning of year | 2021-12-31 | $5,812 |
| Interest on participant loans | 2021-12-31 | $1,981 |
| Value of interest in common/collective trusts at end of year | 2021-12-31 | $19,874 |
| Value of interest in common/collective trusts at beginning of year | 2021-12-31 | $5,380 |
| Net investment gain/loss from registered investment companies (e.g. mutual funds) | 2021-12-31 | $138,977 |
| Net investment gain/loss from pooled separate accounts | 2021-12-31 | $4,479 |
| Net investment gain or loss from common/collective trusts | 2021-12-31 | $158 |
| Were any plan transactions or series of transactions in excess of 5% of the current value of the plan assets | 2021-12-31 | No |
| Was there a failure to transmit to the plan any participant contributions | 2021-12-31 | Yes |
| Has the plan failed to provide any benefit when due under the plan | 2021-12-31 | No |
| Benefit payments and payments to provide benefits directly to participlants or beneficiaries including direct rollovers | 2021-12-31 | $412,817 |
| Contract administrator fees | 2021-12-31 | $12,224 |
| Did the plan have assets held for investment | 2021-12-31 | Yes |
| Did the plan hold any assets whose current value was neither redily determinable on an established market nor set by an independent third party appraiser | 2021-12-31 | No |
| Were all the plan assets eitehr distributed to particpants/beneficiaries, transferred to another plan or brought under the control of the PBGC | 2021-12-31 | No |
| Accountancy firm name | 2021-12-31 | ELLIOT GROUP CPA'S PLLC |
| Accountancy firm EIN | 2021-12-31 | 454771754 |
| 2020 : MEDLY PHARMACY 401K 2020 401k financial data |
|---|
| Unrealized appreciation/depreciation of real estate assets | 2020-12-31 | $0 |
| Unrealized appreciation/depreciation of other (non real estate) assets | 2020-12-31 | $0 |
| Total unrealized appreciation/depreciation of assets | 2020-12-31 | $0 |
| Total transfer of assets to this plan | 2020-12-31 | $0 |
| Total liabilities at end of year (benefit claims payable, operating payabales, acquisition indebtedness and other liabilities) | 2020-12-31 | $0 |
| Total liabilities at beginning of year (benefit claims payable, operating payabales, acquisition indebtedness and other liabilities) | 2020-12-31 | $0 |
| Expenses. Interest paid | 2020-12-31 | $0 |
| Amount of participant contributions which was failed to transmit to the plan within the time period described in 29 CFR 251.3-102 | 2020-12-31 | $0 |
| Total income from all sources (including contributions) | 2020-12-31 | $684,296 |
| Total loss/gain on sale of assets | 2020-12-31 | $0 |
| Total of all expenses incurred | 2020-12-31 | $85,210 |
| Benefit payments and payments to participlants,beneficiaries,insurance carriers and others | 2020-12-31 | $82,255 |
| Expenses. Certain deemed distributions of participant loans | 2020-12-31 | $0 |
| Value of total corrective distributions | 2020-12-31 | $0 |
| Total contributions o plan (from employers,participants, others, non cash contrinutions) | 2020-12-31 | $594,256 |
| Value of total assets at end of year | 2020-12-31 | $761,601 |
| Value of total assets at beginning of year | 2020-12-31 | $162,515 |
| Total of administrative expenses incurred including professional, contract, advisory and management fees | 2020-12-31 | $2,955 |
| Total income from rents | 2020-12-31 | $0 |
| Total interest from all sources | 2020-12-31 | $242 |
| Total dividends received (eg from common stock, registered investment company shares) | 2020-12-31 | $10,020 |
| Has a resolution to terminate the plan been adopted during the plan year or any prior plan year | 2020-12-31 | No |
| Total dividends received from registered investment company shares (eg mutual funds) | 2020-12-31 | $10,020 |
| Administrative expenses professional fees incurred | 2020-12-31 | $0 |
| Was this plan covered by a fidelity bond | 2020-12-31 | No |
| Value of fidelity bond cover | 2020-12-31 | $0 |
| If this is an individual account plan, was there a blackout period | 2020-12-31 | No |
| Total value of distributions paid in property other than in cash, annuity contracts, or publicly traded employer securities | 2020-12-31 | $0 |
| Were there any nonexempt tranactions with any party-in-interest | 2020-12-31 | No |
| Amount of non-exempt transactions with any party-in-interest | 2020-12-31 | $0 |
| Contributions received from participants | 2020-12-31 | $406,479 |
| Participant contributions at end of year | 2020-12-31 | $43,632 |
| Participant contributions at beginning of year | 2020-12-31 | $0 |
| Participant contributions at end of year | 2020-12-31 | $29,373 |
| Participant contributions at beginning of year | 2020-12-31 | $0 |
| Income. Received or receivable in cash from other sources (including rollovers) | 2020-12-31 | $187,777 |
| Expenses. Other payments made (not to insurance carriers or or participants/beneficiaries) | 2020-12-31 | $0 |
| Value of other receiveables (less allowance for doubtful accounts) at end of year | 2020-12-31 | $0 |
| Value of other receiveables (less allowance for doubtful accounts) at beginning of year | 2020-12-31 | $0 |
| Other liabilities (not benefit claims, operating payabales oe acquisition indebtedness) at beginning of year | 2020-12-31 | $0 |
| Other income not declared elsewhere | 2020-12-31 | $0 |
| Administrative expenses (other) incurred | 2020-12-31 | $0 |
| Liabilities. Value of operating payables at beginning of year | 2020-12-31 | $0 |
| Total non interest bearing cash at end of year | 2020-12-31 | $0 |
| Total non interest bearing cash at beginning of year | 2020-12-31 | $0 |
| Did the receive any noncash contributions whose value was neither redily determinable on an established market nor set by an independent third party appraiser | 2020-12-31 | No |
| Income. Non cash contributions | 2020-12-31 | $0 |
| Value of net income/loss | 2020-12-31 | $599,086 |
| Value of net assets at end of year (total assets less liabilities) | 2020-12-31 | $761,601 |
| Value of net assets at beginning of year (total assets less liabilities) | 2020-12-31 | $162,515 |
| Did the plan have a loss casued by fraud or dishonesty (regardless whether reimbursed by fidelity bond) | 2020-12-31 | No |
| Were any loans by the plan or fixed income obligations due to the plan in default | 2020-12-31 | No |
| Amount of loans by the plan or fixed income obligations due to the plan which were in default/classified-as-uncollectible as of the close of the plan year | 2020-12-31 | $0 |
| Were any leases to which the plan was party in default or uncollectible | 2020-12-31 | No |
| Amount of leases to which the plan was a party which were in default/classified-as-uncollectible during the year | 2020-12-31 | $0 |
| Investment advisory and management fees | 2020-12-31 | $0 |
| Value of interest in registered invesment companies (eg mutual funds) at end of year | 2020-12-31 | $677,404 |
| Value of interest in registered invesment companies (eg mutual funds) at beginning of year | 2020-12-31 | $162,515 |
| Value of interest in pooled separate accounts at end of year | 2020-12-31 | $5,812 |
| Value of interest in pooled separate accounts at beginning of year | 2020-12-31 | $0 |
| Interest on participant loans | 2020-12-31 | $242 |
| Income. Interest from loans (other than to participants) | 2020-12-31 | $0 |
| Interest earned on other investments | 2020-12-31 | $0 |
| Income. Interest from US Government securities | 2020-12-31 | $0 |
| Income. Interest from corporate debt instruments | 2020-12-31 | $0 |
| Value of interest in common/collective trusts at end of year | 2020-12-31 | $5,380 |
| Value of interest in common/collective trusts at beginning of year | 2020-12-31 | $0 |
| Interest earned from interest bearing cash (including money market accounts and certificates of deposit) | 2020-12-31 | $0 |
| Expenses. Payments to insurance carriers foe the provision of benefits | 2020-12-31 | $0 |
| Net investment gain/loss from registered investment companies (e.g. mutual funds) | 2020-12-31 | $79,327 |
| Net investment gain/loss from pooled separate accounts | 2020-12-31 | $413 |
| Net investment gain or loss from common/collective trusts | 2020-12-31 | $38 |
| Net gain/loss from 103.12 investment entities | 2020-12-31 | $0 |
| Were any plan transactions or series of transactions in excess of 5% of the current value of the plan assets | 2020-12-31 | No |
| Was there a failure to transmit to the plan any participant contributions | 2020-12-31 | No |
| Has the plan failed to provide any benefit when due under the plan | 2020-12-31 | No |
| Contributions received in cash from employer | 2020-12-31 | $0 |
| Employer contributions (assets) at end of year | 2020-12-31 | $0 |
| Employer contributions (assets) at beginning of year | 2020-12-31 | $0 |
| Income. Dividends from preferred stock | 2020-12-31 | $0 |
| Income. Dividends from common stock | 2020-12-31 | $0 |
| Benefit payments and payments to provide benefits directly to participlants or beneficiaries including direct rollovers | 2020-12-31 | $82,255 |
| Contract administrator fees | 2020-12-31 | $2,955 |
| Liabilities. Value of benefit claims payable at beginning of year | 2020-12-31 | $0 |
| Did the plan have assets held for investment | 2020-12-31 | Yes |
| Did the plan hold any assets whose current value was neither redily determinable on an established market nor set by an independent third party appraiser | 2020-12-31 | No |
| Were all the plan assets eitehr distributed to particpants/beneficiaries, transferred to another plan or brought under the control of the PBGC | 2020-12-31 | No |
| Aggregate proceeds on sale of assets | 2020-12-31 | $0 |
| Aggregate carrying amount (costs) on sale of assets | 2020-12-31 | $0 |
| Liabilities. Value of acquisition indebtedness at beginning of year | 2020-12-31 | $0 |
